Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Clinical trial NCT02188368 · TERMINATED
Trial details
- NCT number
- NCT02188368
- Sponsor
- Oncotherapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-07
- Primary completion
- 2020-10-23
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.